Low-dose aspirin may be better at preventing thromboses in Cushing’s

Low-dose aspirin may be better at preventing thromboses in Cushing’s

Low-dose aspirin, an antiplatelet agent used to reduce blood clotting, may be better than enoxaparin, the current gold standard, at preventing thromboses in people with Cushing’s syndrome, a U.S. study found. Compared with those on enoxaparin, a form of low-molecular weight heparin (LMWH), patients who took low-dose aspirin had a significantly reduced risk of developing pulmonary embolism (PE), a condition in which a blood clot forms in or trave…